Omicron escapes the majority of existing SARS-CoV-2 neutralizing antibodies
2021 · Nature · 2,066 citations
https://doi.org/10.1038/s41586-021-04385-3
Y
Yunlong Cao
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
139
Papers
11.2K
Citations
36
h-index
64
i10-index
Yunlong Cao is an academic researcher from Pioneer (United States). The author has contributed to research in topics: SARS-CoV-2 and COVID-19 Research & COVID-19 Clinical Research Studies & Animal Virus Infections Studies. The author has an h-index of 36, co-authored 119 publications.
ORCID: 0000-0001-5918-1078Papers by this author
worksBA.2.12.1, BA.4 and BA.5 escape antibodies elicited by Omicron infection
2022 · Nature · 1,417 citations
https://doi.org/10.1038/s41586-022-04980-y
Circular RNA vaccines against SARS-CoV-2 and emerging variants
2022 · Cell · 562 citations
https://doi.org/10.1016/j.cell.2022.03.044
Imprinted SARS-CoV-2 humoral immunity induces convergent Omicron RBD evolution
2022 · bioRxiv (Cold Spring Harbor Laboratory) · 394 citations
https://doi.org/10.1101/2022.09.15.507787
Fast evolution of SARS-CoV-2 BA.2.86 to JN.1 under heavy immune pressure
2023 · The Lancet Infectious Diseases · 378 citations
https://doi.org/10.1016/s1473-3099(23)00744-2
Repeated Omicron exposures override ancestral SARS-CoV-2 immune imprinting
2023 · Nature · 250 citations
https://doi.org/10.1038/s41586-023-06753-7
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat